Episteme Prognostics, Inc.
Transforming Cancer Therapy with Precision Epigenetics
About
Episteme Prognostics is a precision medicine company pioneering epigenetic diagnostics to transform how cancer therapy is selected and delivered. Our mission is to help oncologists identify which patients will truly benefit from specific chemotherapies, starting with pancreatic cancer. Our lead test, PancEpistemeDx™, is a DNA‑based, laboratory‑developed test that uses a proprietary ATAC‑array platform to assess chromatin accessibility and predict chemotherapy response in pancreatic ductal adenocarcinoma (PDAC). In clinical studies, the technology has demonstrated high accuracy in distinguishing responders and non‑responders to frontline chemotherapy, addressing a major unmet need in a cancer where only a minority of patients benefit from standard regimens. Founded by academic leaders in surgical oncology and epigenetics, Episteme Prognostics is supported by NIH funding, private investment, and active regulatory engagement as we advance our platform toward clinical adoption. We are committed to enabling more precise, personalized, and effective cancer care through epigenetic biomarkers and decision‑support tools for oncologists and their patients
Founders
- Surajit Dhara
- Steven Leach
Categories
Investors
News
- Episteme Prognostics - 2026 Company Profile & Team - Tracxn · 2026-06-22T00:00:00.000Z
- About - The Divergent Impact Fund · 2026-03-06T00:00:00.000Z
- People - Tessering Biosciences · 2026-03-26T00:00:00.000Z
- Westport AI biotech company gets $4M investment · 2025-01-21T16:17:31.000Z
- AI transforming rare diseases diagnosis and care · 2025-02-27T14:44:05.000Z
- NEC X INVESTS IN PREDICTIVE HEART MONITORING STARTUP, GPX: Press Releases | NEC · 2024-11-13T00:00:00.000Z
Browse similar startups
Related startups
- EuMotus — New York City, NY
- Evvy — New York, NY
- Fourier Health — New York, NY
- Fusia Health — New York, NY
- GeneGenius — New York, NY
- GNOMX Corp. — New York, NY
- Exactics, Inc. — Chicago, IL
- Gordion Bioscience — Boston, MA
- Helicore Biopharma — San Mateo, CA
- ImmunoMetabolix — Bridgewater, NJ
- ImYoo — Mountain View, CA
- Liberate Bio — Boston, MA
Profile updated Jul 29, 2026. Sources: epistemedx.com


